{"transactions":[{"id":2562577,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":135312,"kind":"person","name":"Stergiopoulos Sotirios","position":1,"cik":"0001856641","reported_name":"Stergiopoulos Sotirios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-21T20:05:14.000Z","date":"2021-09-17","kind":"purchase","acquired":true,"shares":34658,"price":10.96,"value":379851.68,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $10.89 to $11.04. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by A2A Pharmaceuticals Inc. Sotirios Stergiopoulos is a member of the Issuer's Board of Directors and an affiliate of A2A Pharmaceuticals Inc. The Reporting Person disclaims beneficial ownership over the shares reported herein except to the extent of his pecuniary interest therein, if any."}],"balance_after":4400000,"source":{"system":"sec-edgar","filing":"0000899243-21-036767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000089924321036767/doc4.xml","form_type":"4"}},{"id":2744612,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":135312,"kind":"person","name":"Stergiopoulos Sotirios","position":1,"cik":"0001856641","reported_name":"Stergiopoulos Sotirios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T23:47:37.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":28911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest in equal monthly installments over a three year period beginning on April 20, 2021, so that all shares shall have vested on April 20, 2024, subject to the Reporting Person continued service to the Issuer through each vesting date."}],"balance_after":28911,"derivative":{"exercise_price":17,"expiration_date":"2031-04-14","underlying":"Common Stock","underlying_shares":28911},"source":{"system":"sec-edgar","filing":"0000899243-21-016299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000089924321016299/doc4.xml","form_type":"4"}}]}